SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 3/02/20 Evolent Health, Inc. 10-K 12/31/19 150:20M |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 2.78M 2: EX-4.8 Instrument Defining the Rights of Security Holders HTML 64K 3: EX-21.1 Subsidiaries List HTML 42K 4: EX-23.1 Consent of Experts or Counsel HTML 40K 5: EX-23.2 Consent of Experts or Counsel HTML 40K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 48K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 48K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 42K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 42K 133: R1 Cover Page HTML 105K 79: R2 Consolidated Balance Sheets HTML 162K 30: R3 Consolidated Balance Sheets (Parenthetical) HTML 52K 112: R4 Consolidated Statements of Operations and HTML 138K Comprehensive Income (Loss) 134: R5 Consolidated Statements of Changes in HTML 144K Shareholders' Equity (Deficit) 80: R6 Consolidated Statements of Cash Flows HTML 166K 31: R7 Organization HTML 48K 115: R8 Basis of Presentation, Summary of Significant HTML 149K Accounting Policies and Change in Accounting Principle 132: R9 Recently Issued Accounting Standards HTML 51K 136: R10 Transactions HTML 155K 84: R11 Revenue Recognition HTML 94K 38: R12 Property and Equipment, Net HTML 58K 55: R13 Goodwill and Intangible Assets, Net HTML 127K 137: R14 Long-term Debt HTML 97K 85: R15 Commitments and Contingencies HTML 108K 39: R16 Leases HTML 80K 56: R17 Earnings (Loss) Per Common Share HTML 76K 135: R18 Stock-based Compensation HTML 186K 86: R19 Income Taxes HTML 202K 28: R20 Employee Benefit Plans HTML 43K 82: R21 Investments In and Advances to Equity Method HTML 97K Investees 130: R22 Non-controlling Interests HTML 73K 113: R23 Fair Value Measurement HTML 168K 29: R24 Related Parties HTML 76K 83: R25 Segment Reporting HTML 173K 131: R26 Reserves for Claims and performance-Based HTML 98K Arrangements 114: R27 Investments HTML 105K 33: R28 Quarterly Results of Operations (Unaudited) HTML 93K 81: R29 Supplemental Cash Flow Information HTML 83K 53: R30 Basis of Presentation, Summary of Significant HTML 245K Accounting Policies and Change in Accounting Principle (Policies) 37: R31 Basis of Presentation, Summary of Significant HTML 140K Accounting Policies and Change in Accounting Principle (Tables) 88: R32 Transactions (Tables) HTML 90K 139: R33 Revenue Recognition (Tables) HTML 74K 52: R34 Property and Equipment, Net (Tables) HTML 58K 36: R35 Goodwill and Intangible Assets, Net (Tables) HTML 120K 87: R36 Long-term Debt (Tables) HTML 58K 138: R37 Commitments and Contingencies (Tables) HTML 78K 54: R38 Leases (Tables) HTML 75K 34: R39 Earnings (Loss) Per Common Share (Tables) HTML 79K 75: R40 Stock-based Compensation (Tables) HTML 167K 27: R41 Income Taxes (Tables) HTML 192K 100: R42 Investments In and Advances to Equity Method HTML 90K Investees Investments In and Advances to Equity Method Investees (Tables) 120: R43 Non-controlling Interests (Tables) HTML 55K 73: R44 Fair Value Measurement (Tables) HTML 219K 25: R45 Related Parties (Tables) HTML 71K 99: R46 Segment Reporting (Tables) HTML 170K 118: R47 Reserves for Claims and performance-Based HTML 91K Arrangements (Tables) 76: R48 Investments (Tables) HTML 106K 22: R49 Quarterly Results of Operations (Unaudited) HTML 93K (Tables) 46: R50 Supplemental Cash Flow Information (Tables) HTML 82K 65: R51 Organization (Details) HTML 45K 140: R52 Basis of Presentation, Summary of Significant HTML 41K Accounting Policies and Change in Accounting Principle - Operating Segments (Details) 91: R53 Basis of Presentation, Summary of Significant HTML 89K Accounting Policies and Change in Accounting Principle - Restricted Cash and Restricted Investments (Details) 48: R54 Basis of Presentation, Summary of Significant HTML 57K Accounting Policies and Change in Accounting Principle - Notes Receivable (Details) 66: R55 Basis of Presentation, Summary of Significant HTML 52K Accounting Policies and Change in Accounting Principle - Estimated Useful Life of Property, Plant and Equipment (Details) 141: R56 Basis of Presentation, Summary of Significant HTML 44K Accounting Policies and Change in Accounting Principle - Research and Development Costs (Details) 92: R57 Basis of Presentation, Summary of Significant HTML 42K Accounting Policies and Change in Accounting Principle - Goodwill (Details) 50: R58 Basis of Presentation, Summary of Significant HTML 53K Accounting Policies and Change in Accounting Principle - Intangible Assets, Net (Details) 62: R59 Basis of Presentation, Summary of Significant HTML 43K Accounting Policies and Change in Accounting Principle - Impairment of Equity Method Investments (Details) 126: R60 Basis of Presentation, Summary of Significant HTML 45K Accounting Policies and Change in Accounting Principle - Revenue Recognition (Details) 104: R61 Basis of Presentation, Summary of Significant HTML 45K Accounting Policies and Change in Accounting Principle - Stock-based Compensation (Details) 18: R62 Recently Issued Accounting Standards (Details) HTML 47K 67: R63 Transactions - Passport (Details) HTML 71K 129: R64 Transactions - New Century Health (Details) HTML 144K 107: R65 Transactions - New Mexico Health Connections HTML 83K (Details) 21: R66 Transactions - Pro Forma Information (Unaudited) HTML 55K (Details) 70: R67 Transactions - Securities Offerings and Sales HTML 143K (Details) 122: R68 Transactions - Asset Acquisitions (Details) HTML 53K 109: R69 Revenue Recognition - Disaggregation of Revenue HTML 59K (Details) 98: R70 Revenue Recognition - Transaction Price Allocated HTML 45K to the Remaining Performance Obligations (Details) 147: R71 Revenue Recognition - Contract Balances (Details) HTML 80K 60: R72 Revenue Recognition - Contract Costs (Details) HTML 52K 44: R73 Property and Equipment, Net (Details) HTML 68K 95: R74 Goodwill and Intangible Assets, Net - Impairment HTML 59K Testing (Details) 144: R75 Goodwill and Intangible Assets, Net - Schedule of HTML 63K Goodwill (Details) 57: R76 Goodwill and Intangible Assets, Net - Intangible HTML 71K Assets, Net (Details) 41: R77 Goodwill and Intangible Assets, Net - Amortization HTML 57K of Intangible Assets (Details) 94: R78 Long-term Debt - Credit Agreement (Details) HTML 84K 149: R79 Long-term Debt - Warrant Agreement (Details) HTML 47K 97: R80 Long-term Debt - 2025 Notes (Details) HTML 92K 146: R81 Long-term Debt - 2021 Notes (Details) HTML 78K 59: R82 Long-term Debt - Convertible Senior Notes Carrying HTML 73K Value (Details) 43: R83 Commitments and Contingencies - Additional HTML 95K Information (Details) 96: R84 Commitments and Contingencies - Purchase HTML 49K Obligations (Details) 145: R85 Commitments and Contingencies - Reinsurance HTML 54K Agreements (Details) 58: R86 Commitments and Contingencies - Concentration Risk HTML 65K (Details) 42: R87 Leases - Narratives (Details) HTML 51K 93: R88 Leases - Material Office Leases (Details) HTML 63K 148: R89 Leases - Components of Lease Expense (Details) HTML 52K 127: R90 Leases - Maturity of Lease Liabilities (Details) HTML 62K 105: R91 Leases - Weighted-average Discount Rate and HTML 44K Weighted-remaining Lease Terms (Details) 19: R92 Earnings (Loss) Per Common Share - Computation of HTML 74K Earnings per Share (Details) 68: R93 Earnings (Loss) Per Common Share - Antidilutive HTML 54K Securities (Details) 128: R94 Stock-based Compensation - 2011 and 2015 Equity HTML 64K Incentive Plans (Details) 106: R95 Stock-based Compensation - Stock-based HTML 63K Compensation Expense (Details) 20: R96 Stock-based Compensation - Unrecognized HTML 59K Compensation Expense (Details) 69: R97 Stock-based Compensation - Stock Options (Details) HTML 74K 124: R98 Stock-based Compensation - Stock Option Activity HTML 95K (Details) 111: R99 Stock-based Compensation - Performance-based Stock HTML 115K Option Awards (Details) 23: R100 Stock-based Compensation - Restricted Stock Units HTML 85K (Details) 77: R101 Stock-based Compensation - Leveraged Stock Units HTML 75K (Details) 116: R102 Stock-based Compensation - Leveraged Stock Units HTML 62K Activity (Details) 101: R103 Stock-based Compensation - Performance-based RSUs HTML 65K (Details) 24: R104 Income Taxes - Narrative (Details) HTML 95K 78: R105 Income Taxes - Schedule of Loss Before Provision HTML 48K for Income Taxes (Details) 117: R106 Income Taxes - Income Tax Expense (Benefit) HTML 75K (Details) 102: R107 Income Taxes - Reconciliation of Statutory Rate to HTML 86K Effective Tax Rate (Details) 26: R108 Income Taxes - Deferred Tax Assets and Liabilities HTML 105K (Details) 74: R109 Income Taxes - Changes in Valuation Allowance HTML 51K (Details) 63: R110 Income Taxes - Changes In Unrecognized Tax HTML 56K Benefits (Details) 51: R111 Employee Benefit Plans (Details) HTML 42K 90: R112 Investments In and Advances to Equity Method HTML 87K Investees (Details) 143: R113 Investments In and Advances to Equity Method HTML 75K Investees - Schedule of Assets and Liabilities and Maximum Loss Exposure of Unconsolidated VIEs (Details) 61: R114 Investments In and Advances to Affiliates - HTML 77K Summarized Financial Information (Details) 49: R115 Non-controlling Interests (Details) HTML 155K 89: R116 Fair Value Measurement - Assets and Liabilities on HTML 84K Recurring Basis (Details) 142: R117 Fair Value Measurement (Details) HTML 50K 64: R118 Fair Value Measurement - Changes in Contingent HTML 51K Consideration and Other (Details) 45: R119 Fair Value Measurement - Valuation Techniques and HTML 100K Significant Unobservable Inputs (Details) 110: R120 Related Parties (Details) HTML 45K 123: R121 Related Parties - Assets and Liabilities (Details) HTML 68K 72: R122 Related Parties - Revenues and Expenses (Details) HTML 68K 17: R123 Segment Reporting (Details) HTML 109K 108: R124 Segment Reporting - Reconciliation of Adjusted HTML 98K EBITDA (Details) 121: R125 Reserves for Claims and performance-Based HTML 70K Arrangements - Claims Reserves (Details) 71: R126 Investments - Investment Summary (Details) HTML 63K 15: R127 Investments - Contractual Maturity (Details) HTML 66K 103: R128 Investments - Unrealized Losses (Details) HTML 49K 125: R129 Quarterly Results of Operations (Unaudited) HTML 68K (Details) 150: R130 Supplemental Cash Flow Information (Details) HTML 94K 47: R9999 Uncategorized Items - evh12311910-k.htm HTML 42K 40: XML IDEA XML File -- Filing Summary XML 285K 32: XML XBRL Instance -- evh12311910-k_htm XML 5.24M 119: EXCEL IDEA Workbook of Financial Reports XLSX 198K 11: EX-101.CAL XBRL Calculations -- evh-20191231_cal XML 432K 12: EX-101.DEF XBRL Definitions -- evh-20191231_def XML 1.64M 13: EX-101.LAB XBRL Labels -- evh-20191231_lab XML 3.24M 14: EX-101.PRE XBRL Presentations -- evh-20191231_pre XML 2.23M 10: EX-101.SCH XBRL Schema -- evh-20191231 XSD 330K 16: JSON XBRL Instance as JSON Data -- MetaLinks 667± 1.06M 35: ZIP XBRL Zipped Folder -- 0001628908-20-000032-xbrl Zip 748K
|
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/2/20 | 4 | ||
For Period end: | 12/31/19 | 8-K | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/15/21 Evolent Health, Inc. S-8 6/15/21 4:87K 2/26/21 Evolent Health, Inc. 10-K 12/31/20 152:19M |